154 related articles for article (PubMed ID: 26610257)
61. Plant derived anti-cancerous secondary metabolites as multipronged inhibitor of COX, Topo, and aromatase: molecular modeling and dynamics simulation analyses.
Singh S; Awasthi M; Pandey VP; Dwivedi UN
J Biomol Struct Dyn; 2017 Nov; 35(14):3082-3097. PubMed ID: 27667581
[TBL] [Abstract][Full Text] [Related]
62. Syntheses and characterization of nimesulide derivatives for dual enzyme inhibitors of both cyclooxygenase-1/2 and 5-lipoxygenase.
Li Y; Chen SH; Ou TM; Tan JH; Li D; Gu LQ; Huang ZS
Bioorg Med Chem; 2011 Mar; 19(6):2074-83. PubMed ID: 21349729
[TBL] [Abstract][Full Text] [Related]
63. A computational prospect to aspirin side effects: aspirin and COX-1 interaction analysis based on non-synonymous SNPs.
Marjan MN; Hamzeh MT; Rahman E; Sadeq V
Comput Biol Chem; 2014 Aug; 51():57-62. PubMed ID: 24953043
[TBL] [Abstract][Full Text] [Related]
64. Cyclooxygenase (COX) and 5-lipoxygenase (5-LOX) selectivity of COX inhibitors.
Sud'ina GF; Pushkareva MA; Shephard P; Klein T
Prostaglandins Leukot Essent Fatty Acids; 2008 Feb; 78(2):99-108. PubMed ID: 18280718
[TBL] [Abstract][Full Text] [Related]
65. Anti-inflammatory, antioxidant, anti-tyrosinase and phenolic contents of four Podocarpus species used in traditional medicine in South Africa.
Abdillahi HS; Finnie JF; Van Staden J
J Ethnopharmacol; 2011 Jul; 136(3):496-503. PubMed ID: 20633623
[TBL] [Abstract][Full Text] [Related]
66. Binding of ibuprofen, ketorolac, and diclofenac to COX-1 and COX-2 studied by saturation transfer difference NMR.
Viegas A; Manso J; Corvo MC; Marques MM; Cabrita EJ
J Med Chem; 2011 Dec; 54(24):8555-62. PubMed ID: 22091869
[TBL] [Abstract][Full Text] [Related]
67. Synthesis and in-silico studies of some diaryltriazole derivatives as potential cyclooxygenase inhibitors.
Radwan AA; elTahir KE
Arch Pharm Res; 2013 May; 36(5):553-63. PubMed ID: 23479193
[TBL] [Abstract][Full Text] [Related]
68. Anti-inflammatory activity of copao (Eulychnia acida Phil., Cactaceae) fruits.
Jiménez-Aspee F; Alberto MR; Quispe C; Soriano Mdel P; Theoduloz C; Zampini IC; Isla MI; Schmeda-Hirschmann G
Plant Foods Hum Nutr; 2015 Jun; 70(2):135-40. PubMed ID: 25682221
[TBL] [Abstract][Full Text] [Related]
69. Dual acting anti-inflammatory drugs: a reappraisal.
Bertolini A; Ottani A; Sandrini M
Pharmacol Res; 2001 Dec; 44(6):437-50. PubMed ID: 11735348
[TBL] [Abstract][Full Text] [Related]
70. Design, synthesis, and biological evaluation of 6-substituted-3-(4-methanesulfonylphenyl)-4-phenylpyran-2-ones: a novel class of diarylheterocyclic selective cyclooxygenase-2 inhibitors.
Praveen Rao PN; Amini M; Li H; Habeeb AG; Knaus EE
J Med Chem; 2003 Nov; 46(23):4872-82. PubMed ID: 14584938
[TBL] [Abstract][Full Text] [Related]
71. Compounds from the insect Blaps japanensis with COX-1 and COX-2 inhibitory activities.
Yan YM; Li LJ; Qin XC; Lu Q; Tu ZC; Cheng YX
Bioorg Med Chem Lett; 2015 Jun; 25(12):2469-72. PubMed ID: 25980909
[TBL] [Abstract][Full Text] [Related]
72. Interactions of selected indole derivatives with COX-2 and their in silico structure modifications towards the development of novel NSAIDs.
Dileep KV; Remya C; Tintu I; Sadasivan C
J Biomol Struct Dyn; 2014; 32(11):1855-63. PubMed ID: 24053423
[TBL] [Abstract][Full Text] [Related]
73. Synthesis of 2-methyl-3-indolylacetic derivatives as anti-inflammatory agents that inhibit preferentially cyclooxygenase 1 without gastric damage.
Perissutti E; Fiorino F; Renner C; Severino B; Roviezzo F; Sautebin L; Rossi A; Cirino G; Santagada V; Caliendo G
J Med Chem; 2006 Dec; 49(26):7774-80. PubMed ID: 17181159
[TBL] [Abstract][Full Text] [Related]
74. Interactive Analysis of TX-1123 with Cyclo-oxygenase: Design of COX2 Selective TX Analogs.
Ohkura K; Tatematsu Y; Kawaguchi Y; Uto Y; Hori H
Anticancer Res; 2017 Jul; 37(7):3849-3854. PubMed ID: 28668885
[TBL] [Abstract][Full Text] [Related]
75. Design of novel N-phenylnicotinamides as selective cyclooxygenase-1 inhibitors.
Shi L; Li ZL; Yang Y; Zhu ZW; Zhu HL
Bioorg Med Chem Lett; 2011 Jan; 21(1):121-4. PubMed ID: 21144750
[TBL] [Abstract][Full Text] [Related]
76. Design, synthesis, and anti-inflammatory evaluation of novel diphenylthiazole-thiazolidinone hybrids.
Abdelazeem AH; Salama SA; Maghrabi IA
Arch Pharm (Weinheim); 2015 Jul; 348(7):518-30. PubMed ID: 25989149
[TBL] [Abstract][Full Text] [Related]
77. Origin of the Enigmatic Stepwise Tight-Binding Inhibition of Cyclooxygenase-1.
Shamsudin Y; Kazemi M; Gutiérrez-de-Terán H; Åqvist J
Biochemistry; 2015 Dec; 54(49):7283-91. PubMed ID: 26562384
[TBL] [Abstract][Full Text] [Related]
78. The structure of mammalian cyclooxygenases.
Garavito RM; Mulichak AM
Annu Rev Biophys Biomol Struct; 2003; 32():183-206. PubMed ID: 12574066
[TBL] [Abstract][Full Text] [Related]
79. In vitro COX-1 and COX-2 enzyme inhibitory activities of iridoids from Penstemon barbatus, Castilleja tenuiflora, Cresentia alata and Vitex mollis.
Ramírez-Cisneros MÁ; Rios MY; Aguilar-Guadarrama AB; Rao PP; Aburto-Amar R; Rodríguez-López V
Bioorg Med Chem Lett; 2015 Oct; 25(20):4505-8. PubMed ID: 26351040
[TBL] [Abstract][Full Text] [Related]
80. Design, synthesis and biological screening of new 4-thiazolidinone derivatives with promising COX-2 selectivity, anti-inflammatory activity and gastric safety profile.
Abdellatif KR; Abdelgawad MA; Elshemy HA; Alsayed SS
Bioorg Chem; 2016 Feb; 64():1-12. PubMed ID: 26561742
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
